NCT04606823

Brief Summary

This multi-centre study funded by Oticon Medical AB will be conducted at seven hospitals across Europe (UK, Sweden, Denmark and the Netherlands). In total, 50 adult patients with a hearing loss that are already planned for treatment with a percutaneous (through the skin) bone-anchored hearing system (BAHS) will be included in the study. The purpose of the study is to investigate the rate of successful BAHS use after implantation of the Ponto implant system using a minimally invasive surgical technique.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
4 countries

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 28, 2020

Completed
7 days until next milestone

Study Start

First participant enrolled

November 4, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2023

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

January 29, 2026

Completed
Last Updated

January 29, 2026

Status Verified

January 1, 2026

Enrollment Period

1.8 years

First QC Date

October 22, 2020

Results QC Date

March 14, 2025

Last Update Submit

January 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Implants With Reliable Anchorage for a Sound Processor

    The variables assessed to determine reliable anchorage in the study are implant survival and stability, skin reactions, skin overgrowth and pain preventing use of the sound processor. For a positive outcome of the primary endpoint (reliable anchorage), the implant should be in place and stable without any adverse skin reactions, skin overgrowth or pain preventing usage of the sound processor.

    3 months after implant surgery

Secondary Outcomes (15)

  • Number of Implants With Reliable Anchorage for a Sound Processor

    12 months after implant surgery

  • Implant Survival

    12 months after implant surgery

  • Implant Stability

    12 months after implant surgery

  • Holgers Score Distribution

    9 days, 5 weeks, 3-, 6-, and 12 months after implant surgery, and unplanned visits

  • Max Holgers Score

    12 months after implant surgery

  • +10 more secondary outcomes

Study Arms (1)

Single-arm

OTHER

In this single-arm study the patients will be undergoing a minimally invasive surgery after which they will re-visit the clinic at five occasions for follow-up visits (1-3 extra compared to routine clinical practice at the hospitals) and complete a quality of life-questinnaire three months after surgery.

Procedure: Minimally invasive surgeryOther: Glasgow Benefit Inventory (GBI)Other: Additional follow-up visits after surgery

Interventions

A quality of life-questionnaire is to be completed by the subjects at one occasion.

Single-arm

There are 1-3 additional follow-up visits after surgery (compared to the routine clinical practice of the surgeons/clinics).

Single-arm

The subjects will be implanted with a bone anchored hearing system using a minimally invasive surgery.

Single-arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Patient indicated for surgical intervention with a bone anchored hearing system
  • Signed informed consent
  • Adequate bone quality to allow for a Ponto implant insertion, as judged by the investigator, and an expected bone thickness above 5 mm, where no complications during surgery are expected
  • Skin thickness of 12 mm or less at the implant site

You may not qualify if:

  • Patient undergoing re-implantation
  • Patient who are unable or unwilling to follow investigational procedures/requirements, e.g. to complete quality of life scales
  • Known condition or previous treatment that could jeopardize skin condition and wound healing over time as judged by the investigator (e.g. uncontrolled diabetes, previous radiotherapy in the area of interest)
  • Known medical condition that contraindicate surgery as judged by the investigator
  • Known and/or planned pregnancy at time of surgery
  • Any other known condition that the investigator determines could interfere with compliance or investigation assessments
  • Simultaneous participation in another clinical investigation with pharmaceutical and/or medical device which might cause interference with investigation participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Aalborg University Hospital

Aalborg, 9000, Denmark

Location

Univerisity Medical Center Groningen

Groningen, Netherlands

Location

Radboud University Medical Center

Nijmegen, 6525EX, Netherlands

Location

Sahlgrenska University Hospital

Gothenburg, 413 46, Sweden

Location

University Hospitals Birmingham NHS Foundation Trust

Birmingham, B15 2WB, United Kingdom

Location

Cambridge University Hospitals NHS Foundation Trust

Cambridge, CB2 0QQ, United Kingdom

Location

Guy's and St Thomas' NHS Foundation Trust

London, SE1 7EH, United Kingdom

Location

Related Publications (1)

  • Teunissen EM, Aukema TW, Banga R, Eeg-Olofsson M, Hol MKS, Hougaard DD, Tysome JR, Johansson ML, Svensson S, Powell HRF. Evaluation of Clinical Performance of Ponto Implantation Using a Minimally Invasive Surgical Technique-A Prospective Multicenter Study. Otol Neurotol. 2024 Oct 1;45(9):1037-1044. doi: 10.1097/MAO.0000000000004315. Epub 2024 Aug 26.

MeSH Terms

Conditions

Hearing Loss

Interventions

Minimally Invasive Surgical Procedures

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Procedures, Operative

Results Point of Contact

Title
Director of Clinical Affairs
Organization
Oticon Medical

Study Officials

  • Harry Powell, MD

    Guy's and St Thomas' NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2020

First Posted

October 28, 2020

Study Start

November 4, 2020

Primary Completion

August 9, 2022

Study Completion

April 26, 2023

Last Updated

January 29, 2026

Results First Posted

January 29, 2026

Record last verified: 2026-01

Locations